- Home
- BEP vs BBIO Comparison
BEP vs BBIO Comparison
Compare BEP & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEP
- BBIO
- Stock Information
- Founded
- BEP 1999
- BBIO 2015
- Country
- BEP Canada
- BBIO United States
- Employees
- BEP N/A
- BBIO N/A
- Industry
- BEP Electric Utilities: Central
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- BEP Utilities
- BBIO Health Care
- Exchange
- BEP Nasdaq
- BBIO Nasdaq
- Market Cap
- BEP 7.0B
- BBIO 6.7B
- IPO Year
- BEP N/A
- BBIO 2019
- Fundamental
- Price
- BEP $23.80
- BBIO $34.25
- Analyst Decision
- BEP Buy
- BBIO Strong Buy
- Analyst Count
- BEP 7
- BBIO 12
- Target Price
- BEP $29.00
- BBIO $57.09
- AVG Volume (30 Days)
- BEP 477.1K
- BBIO 2.9M
- Earning Date
- BEP 05-02-2025
- BBIO 04-29-2025
- Dividend Yield
- BEP 6.11%
- BBIO N/A
- EPS Growth
- BEP N/A
- BBIO N/A
- EPS
- BEP N/A
- BBIO N/A
- Revenue
- BEP $5,964,000,000.00
- BBIO $127,415,000.00
- Revenue This Year
- BEP $13.87
- BBIO $89.10
- Revenue Next Year
- BEP $6.70
- BBIO $57.07
- P/E Ratio
- BEP N/A
- BBIO N/A
- Revenue Growth
- BEP 14.71
- BBIO N/A
- 52 Week Low
- BEP $19.29
- BBIO $21.62
- 52 Week High
- BEP $29.56
- BBIO $39.54
- Technical
- Relative Strength Index (RSI)
- BEP 54.68
- BBIO 50.58
- Support Level
- BEP $22.64
- BBIO $31.77
- Resistance Level
- BEP $24.27
- BBIO $33.93
- Average True Range (ATR)
- BEP 0.55
- BBIO 1.28
- MACD
- BEP -0.04
- BBIO -0.09
- Stochastic Oscillator
- BEP 52.57
- BBIO 57.14
About BEP Brookfield Renewable Partners L.P.
Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners and Brookfield Renewable Corp.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.